Physician profile
Radoslav Jovanovic
NPI 1851399521
$2,104.61
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $814 · 2020: $577 · 2021: $700 · 2022: $14.20.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $785.93 | 2019-2021 | |
| Therapeuticsmd, INC. | $337.89 | 2019-2022 | |
| Duchesnay USA Incorporated | $171.57 | 2019 | |
| Millicent US INC | $126.10 | 2019-2020 | |
| Avion Pharmaceuticals | $82.33 | 2020-2021 | |
| Evofem Biosciences, INC. | $72.58 | 2020-2021 | |
| Vertical Pharmaceuticals, LLC | $62.47 | 2019 | |
| Eisai INC. | $59.71 | 2019 | |
| Merz North America, INC. | $51.73 | 2019-2020 | |
| Lupin INC. | $48.59 | 2019-2021 | |
| Exeltis, USA INC. | $46.38 | 2019-2021 | |
| Mission Pharmacal Company | $44.07 | 2019 | |
| Roche Diagnostics Corporation | $25.62 | 2019 | |
| Amag Pharmaceuticals, INC. | $24.85 | 2019 | |
| Myovant Sciences INC. | $24.53 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $23.23 | 2020 | |
| Hologic Sales and Service, LLC | $22.50 | 2019 | |
| Agile Therapeutics, INC. | $22.04 | 2021 | |
| Novo Nordisk INC | $20.37 | 2019 | |
| Merck Sharp & Dohme LLC | $18.87 | 2019 | |
| Smith+Nephew, INC. | $17.66 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.59 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Radoslav Jovanovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.